RenovoRx (RNXT) Earnings Date & Reports

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

RNXT is expected to report earnings to fall 29.17% to -8 cents per share on May 19

Q1'25

Est.

$-0.09

Q4'24

Missed

by $0.02

Q3'24

Beat

by $0.02

Q2'24

Est.

$-0.10

Q1'24

Est.

$-0.07

The last earnings report on April 01 showed earnings per share of -11 cents, missing the estimate of -10 cents. With 145.65K shares outstanding, the current market capitalization sits at 31.06M.

View a ticker or compare two or three

Compare

RNXT